Chemomab Therapeutics Ltd ADR (CMMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,951 | -27,124 | -13,798 | -9,806 | -4,742 |
| Depreciation Amortization | 24 | 281 | 66 | 51 | 41 |
| Accounts receivable | -99 | N/A | -3,496 | 204 | 116 |
| Accounts payable and accrued liabilities | 68 | 1,076 | 287 | 44 | -491 |
| Other Working Capital | 555 | 4,657 | -3,424 | 289 | 506 |
| Other Operating Activity | 161 | 4,652 | 6,142 | 703 | 838 |
| Operating Cash Flow | $-5,242 | $-16,458 | $-14,223 | $-8,515 | $-3,732 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -24 | N/A | N/A | N/A | N/A |
| PPE Investments | -38 | -95 | -213 | -34 | -75 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 153 |
| Investing Cash Flow | $-62 | $-95 | $-213 | $-34 | $78 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 4,050 | N/A | N/A |
| Debt Repayment | N/A | N/A | -4,033 | N/A | N/A |
| Common Stock Issued | 4,750 | 30,500 | 22,900 | 5,665 | 6,503 |
| Other Financing Activity | 0 | -3,879 | -2,298 | -423 | -440 |
| Financing Cash Flow | $4,750 | $26,621 | $20,619 | $5,242 | $6,063 |
| Exchange Rate Effect | N/A | N/A | N/A | 197 | -48 |
| Beginning Cash Position | 12,281 | 7,637 | 1,454 | 4,564 | 2,203 |
| End Cash Position | 11,727 | 17,705 | 7,637 | 1,454 | 4,564 |
| Net Cash Flow | $-554 | $10,068 | $6,183 | $-3,110 | $2,361 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,242 | -16,458 | -14,223 | -8,515 | -3,732 |
| Capital Expenditure | -38 | -95 | -213 | -34 | -75 |
| Free Cash Flow | -5,280 | -16,553 | -14,436 | -8,549 | -3,807 |